• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

European Stroke Conference, Nice, May 6-9, 2014
Cerebrovasc Dis 2014;37:1 –709
Source: Cerebrovascular Diseases - November 4, 2021 Category: Neurology Source Type: research

What is the Price of the Potential for a Meaningful Recovery following Intracerebral Hemorrhage?
In this issue of the Journal of Stroke and Cerebrovascular Diseases, Vardanyan and colleagues report on the cost-utility of minimally invasive surgery (MIS) with thrombolysis for spontaneous intracerebral hemorrhage (ICH) from the perspective of the United Kingdom (UK) National Health Service (NHS)1 using data from the Minimally Invasive Surgery Plus Alteplase in Intracerebral Hemorrhage Evacuation (MISTIE III) trial2 and the UK Sentinel Stroke National Audit Programme (SSNAP).3 The economic evaluation revealed that the incremental cost-effectiveness ratio for MIS with thrombolysis fell significantly above the UK's Nationa...
Source: Journal of Stroke and Cerebrovascular Diseases - July 27, 2021 Category: Neurology Authors: Lourdes R. Carhuapoma, Avni Kapadia, Henry A. Glick, Daniel F. Hanley Source Type: research

Prognostic factors for patients with acute ischemic stroke treated by mechanical thrombectomy
【Background and Purpose】To elucidate the prognostic factors for mechanical thrombectomy (MT), we investigated (retrospectively) a series of patients with acute ischemic stroke (AIS) treated with MT in our hospital.
Source: Journal of Stroke and Cerebrovascular Diseases - March 18, 2017 Category: Neurology Authors: Katsuharu Kameda, Junji Uno, Shota Yoshida, Ryosuke Otsuji, Nice Ren, Shintaro Nagaoka, Kazushi Maeda, Yoshiaki Ikai, Hidefuku Gi Source Type: research

Editorial Time for action on atrial fibrillation
The incidence of atrial fibrillation, a common and treatable risk factor for ischaemic stroke, is predicted to increase in the coming decades, elevating the status of this arrhythmia to that of a public health priority. The growing importance of this condition is reflected by the publication in July, 2015, of two documents: the research report for the Future of Anticoagulation Initiative on the future of atrial fibrillation management in Europe; and the UK National Institute for Health and Care Excellence (NICE) Quality Standard on the treatment and management of atrial fibrillation.
Source: Lancet Neurology - August 10, 2015 Category: Neurology Authors: The Lancet Neurology Tags: Editorial Source Type: research